Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.162EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.426EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.426EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.402EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.402EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.590EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.590EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.116EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.116EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.496EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.496EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.438.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.49 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.49 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.507EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.507EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.495EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.495EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.294EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.294EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.453EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.453EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.44EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.350EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.350EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.304EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.304EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.177EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.177EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.301EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.301EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.308EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.308EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.210EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.210EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.325EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.325EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FP.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.443EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.443EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.595.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.178EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used